vs
Allot Ltd.（ALLT）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Allot Ltd.的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$24.1M vs $19.6M），Allot Ltd.净利率更高（-7.0% vs -177.4%，领先170.4%），Allot Ltd.同比增速更快（8.5% vs -11.5%），Allot Ltd.自由现金流更多（$4.0M vs $-23.1M）
Allot Ltd.是一家以色列高科技企业，前身为Allot Communications，核心业务为电信软件开发，公司总部设于以色列霍德哈沙伦，在通信技术软件领域拥有深厚的技术积累。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ALLT vs LAB — 直观对比
营收规模更大
ALLT
是对方的1.2倍
$19.6M
营收增速更快
ALLT
高出20.0%
-11.5%
净利率更高
ALLT
高出170.4%
-177.4%
自由现金流更多
ALLT
多$27.1M
$-23.1M
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.1M | $19.6M |
| 净利润 | $-1.7M | $-34.7M |
| 毛利率 | 72.1% | 48.5% |
| 营业利润率 | -1.7% | -168.5% |
| 净利率 | -7.0% | -177.4% |
| 营收同比 | 8.5% | -11.5% |
| 净利润同比 | 49.6% | -28.8% |
| 每股收益（稀释后） | $-0.04 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLTLAB
| Q3 25 | — | $19.6M | ||
| Q2 25 | $24.1M | $21.8M | ||
| Q1 25 | $23.1M | $40.8M | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | $22.2M | $22.5M | ||
| Q1 24 | — | $45.5M | ||
| Q4 23 | — | $28.2M | ||
| Q3 23 | — | $25.4M |
净利润ALLTLAB
| Q3 25 | — | $-34.7M | ||
| Q2 25 | $-1.7M | $-33.5M | ||
| Q1 25 | $-332.0K | $-26.0M | ||
| Q3 24 | — | $-26.9M | ||
| Q2 24 | $-3.4M | $-45.7M | ||
| Q1 24 | — | $-32.2M | ||
| Q4 23 | — | $-19.8M | ||
| Q3 23 | — | $-21.0M |
毛利率ALLTLAB
| Q3 25 | — | 48.5% | ||
| Q2 25 | 72.1% | 48.8% | ||
| Q1 25 | 69.3% | 48.4% | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | 68.5% | 46.1% | ||
| Q1 24 | — | 53.1% | ||
| Q4 23 | — | 47.6% | ||
| Q3 23 | — | 44.0% |
营业利润率ALLTLAB
| Q3 25 | — | -168.5% | ||
| Q2 25 | -1.7% | -118.1% | ||
| Q1 25 | -3.1% | -80.8% | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | -15.2% | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% | ||
| Q3 23 | — | -83.5% |
净利率ALLTLAB
| Q3 25 | — | -177.4% | ||
| Q2 25 | -7.0% | -153.7% | ||
| Q1 25 | -1.4% | -63.8% | ||
| Q3 24 | — | -122.0% | ||
| Q2 24 | -15.1% | -203.3% | ||
| Q1 24 | — | -70.6% | ||
| Q4 23 | — | -70.2% | ||
| Q3 23 | — | -82.8% |
每股收益（稀释后）ALLTLAB
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-0.04 | $-0.09 | ||
| Q1 25 | $-0.01 | $-0.07 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $-0.09 | $-0.12 | ||
| Q1 24 | — | $-0.27 | ||
| Q4 23 | — | $-0.24 | ||
| Q3 23 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $99.7M | $399.7M |
| 总资产 | $154.1M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALLTLAB
| Q3 25 | — | $129.4M | ||
| Q2 25 | $60.1M | $158.6M | ||
| Q1 25 | $10.1M | $150.9M | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | $15.9M | $269.8M | ||
| Q1 24 | — | $287.1M | ||
| Q4 23 | — | $51.7M | ||
| Q3 23 | — | $79.7M |
总债务ALLTLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M | ||
| Q3 23 | — | $64.6M |
股东权益ALLTLAB
| Q3 25 | — | $399.7M | ||
| Q2 25 | $99.7M | $424.5M | ||
| Q1 25 | $50.0M | $454.6M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | $46.7M | $510.3M | ||
| Q1 24 | — | $577.3M | ||
| Q4 23 | — | $-148.1M | ||
| Q3 23 | — | $-131.7M |
总资产ALLTLAB
| Q3 25 | — | $539.6M | ||
| Q2 25 | $154.1M | $557.0M | ||
| Q1 25 | $140.3M | $579.6M | ||
| Q3 24 | — | $681.5M | ||
| Q2 24 | $132.5M | $708.7M | ||
| Q1 24 | — | $777.7M | ||
| Q4 23 | — | $323.1M | ||
| Q3 23 | — | $339.3M |
负债/权益比ALLTLAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $4.0M | $-23.1M |
| 自由现金流率自由现金流/营收 | 16.5% | -118.1% |
| 资本支出强度资本支出/营收 | 1.7% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ALLTLAB
| Q3 25 | — | $-22.2M | ||
| Q2 25 | $4.4M | $-20.7M | ||
| Q1 25 | $1.7M | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | $1.2M | $-39.0M | ||
| Q1 24 | — | $-62.5M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-11.4M |
自由现金流ALLTLAB
| Q3 25 | — | $-23.1M | ||
| Q2 25 | $4.0M | $-22.6M | ||
| Q1 25 | $1.4M | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | $217.0K | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-12.3M |
自由现金流率ALLTLAB
| Q3 25 | — | -118.1% | ||
| Q2 25 | 16.5% | -103.6% | ||
| Q1 25 | 6.1% | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | 1.0% | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% | ||
| Q3 23 | — | -48.6% |
资本支出强度ALLTLAB
| Q3 25 | — | 4.5% | ||
| Q2 25 | 1.7% | 8.7% | ||
| Q1 25 | 1.2% | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | 4.3% | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 3.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLT
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
